| 000 | 01481 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512054734.0 | ||
| 264 | 0 | _c19870326 | |
| 008 | 198703s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/0024-3205(87)90298-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrevor, A J | |
| 245 | 0 | 0 |
_aBioactivation of MPTP: reactive metabolites and possible biochemical sequelae. _h[electronic resource] |
| 260 |
_bLife sciences _cFeb 1987 |
||
| 300 |
_a713-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _a1-Methyl-4-phenylpyridinium |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 | _aFree Radicals |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPyridines _xmetabolism |
| 650 | 0 | 4 |
_aPyridinium Compounds _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 700 | 1 | _aCastagnoli, N | |
| 700 | 1 | _aCaldera, P | |
| 700 | 1 | _aRamsay, R R | |
| 700 | 1 | _aSinger, T P | |
| 773 | 0 |
_tLife sciences _gvol. 40 _gno. 8 _gp. 713-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(87)90298-0 _zAvailable from publisher's website |
| 999 |
_c3498379 _d3498379 |
||